Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer

TNBC is an aggressive breast cancer subtype that does not express hormone receptors (estrogen and progesterone receptors, ER and PR) or amplified human epidermal growth factor receptor type 2 (HER2), and there currently exist no targeted therapies effective against it. Consequently, finding new mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Banda, Malathi, Speyer, Cecilia L., Semma, Sara N., Osuala, Kingsley O., Kounalakis, Nicole, Torres Torres, Keila E., Barnard, Nicola J., Kim, Hyunjin J., Sloane, Bonnie F., Miller, Fred R., Goydos, James S., Gorski, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880256/
https://www.ncbi.nlm.nih.gov/pubmed/24404125
http://dx.doi.org/10.1371/journal.pone.0081126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880256/
https://www.ncbi.nlm.nih.gov/pubmed/24404125
http://dx.doi.org/10.1371/journal.pone.0081126

Ejemplares similares